Not applicableNo Longer AvailableNCT00655252
What this trial is testing
Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy
Who this might be right for
Metastatic Renal Cell Cancer
Novartis Pharmaceuticals